AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
N -arachidonoylphenolamine (AM404), a paracetamol metabolite, is a potent agonist of the transient receptor potential vanilloid type 1 (TRPV1) and low-affinity ligand of the cannabinoid receptor type 1 (CB1). There is evidence that AM404 exerts its pharmacological effects in immune cells. However, the effect of AM404 on the production of inflammatory mediators of the arachidonic acid pathway in activated microglia is still not fully elucidated. In the present study, we investigated the effects of AM404 on the eicosanoid production induced by lipopolysaccharide (LPS) in organotypic hippocampal slices culture (OHSC) and primary microglia cultures using Western blot, immunohistochemistry, and ELISA. Our results show that AM404 inhibited LPS-mediated prostaglandin E 2 (PGE 2 ) production in OHSC, and LPS-stimulated PGE 2 release was totally abolished in OHSC if microglial cells were removed. In primary microglia cultures, AM404 led to a significant dose-dependent decrease in the release of PGE 2 , independent of TRPV1 or CB1 receptors. Moreover, AM404 also inhibited the production of PGD 2 and the formation of reactive oxygen species (8-iso-PGF 2 alpha) with a reversible reduction of COX-1- and COX-2 activity. Also, it slightly decreased the levels of LPS-induced COX-2 protein, although no effect was observed on LPS-induced mPGES-1 protein synthesis. This study provides new significant insights about the potential anti-inflammatory role of AM404 and new mechanisms of action of paracetamol on the modulation of prostaglandin production by activated microglia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, several molecular actors targeted by the bioactive AM404, including the Cav3.2 calcium channel, the cannabinoid CB1 receptors and TRPV1 receptors, would participate in the MoA.10,20,21”
From An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact (2023) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 1×
“Immune cells express the cannabinoid receptors type 1 and type 2, albeit CB2 appears to be the predominant isoform [57, 58].”
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · cited 1×
“Acetaminophen produces a weak inhibition of COX, and it has been proposed that acetaminophen acts on COX-3, a brain-specific isoform of COX and slice variant of constitutive enzyme COX-1 [32, 33].”
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,899 · cited 1×
“8-iso-PGF2α is produced by the non-enzymatic peroxidation of arachidonic acid in membrane phospholipids and is considered a reliable and highly sensitive marker to assess oxidative stress [31].”
An Introduction to the Endogenous Cannabinoid System
Lu, H.-C., & Mackie, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.028 · Cited by 1,234 · cited 1×
“Moreover, microglia can also express TRPV1 that mediate some endocannabinoid actions [59, 60].”
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813 · cited 4×
“AM404 is a potent agonist of the transient receptor potential vanilloid type 1 (TRPV1) [8], a low-affinity ligand of the cannabinoid receptor type 1 (CB1) [3, 9], and an anandamide membrane transporter (AMT) blocker [10, 11].”
InfluentialFLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779 · cited 11×
“The pharmacokinetics of AM404 formation in the CNS after acetaminophen administration has been studied by two different groups, Högestätt et al. [3] and Murasamatsu et al. [7].”
InfluentialParacetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
Samuelsson, B., Granstrom, E., Green, K., Hamberg, M., & Hammarstrom, S. (1975) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.44.070175.003321 · Cited by 529
Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
Stella, N. (2010) · Glia · doi:10.1002/glia.20983 · Cited by 527 · cited 1×
“Moreover, microglia can also express TRPV1 that mediate some endocannabinoid actions [59, 60].”
Organotypic brain slice cultures: A review
Humpel, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.086 · Cited by 480 · cited 1×
“OHSC is a well-established brain tissue model maintaining the main architecture of the cells, and its complex system provides a good tool to understand cellular and molecular processes of the brain in vitro [40, 41].”
Cited by
Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
Ayoub, S. S. (2021) · Temperature · doi:10.1080/23328940.2021.1886392 · Cited by 223
“[105] Saliba SW, Marcotegui AR, Fortwängler E, et al.”
BackgroundParacetamol – An old drug with new mechanisms of action
Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190
The Endocannabinoid System of Animals
Silver, R. (2019) · Animals · doi:10.3390/ani9090686 · Cited by 197
“Non-steroidal anti-inflammatory drugs are COX-2 inhibitors that work, in part, by reducing the enzymatic degradation of the endocannabinoid anandamide [49].”
BackgroundAnti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells
Saliba, S. W., Jauch, H., Gargouri, B., Keil, A., Hurrle, T., Volz, N., Mohr, F., van der Stelt, M., Bräse, S., & Fiebich, B. L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1362-7 · Cited by 90
Self-citationMallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83
“Theoretically, combining two analgesics with different mechanisms of action potentiates their analgesic actions without increasing their doses and compromising the safety outcomes.103–106 Paracetamol has linear and consistent pharmacokinetics, and its tolerable profile makes it a good option when a combination is requ…”
BackgroundInfluential
Metadata
- Authors
- Saliba, S. W., Marcotegui, A. R., Fortwängler, E., Ditrich, J., Perazzo, J. C., Muñoz, E., de Oliveira, A. C. P., & Fiebich, B. L.
- Affiliations
- University of Freiburg (DE)
- Universidad de Buenos Aires (AR)
- Corresponding author
- Saliba, Soraya Wilke
- Fiebich, Bernd L.
- Venue
- Journal of Neuroinflammation
- Published
- 2017-12
- Volume
- 14
- Issue
- 1
- Pages
- 246-246
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC5729401
- OpenAlex
- W2775186789
- Cited by
- 62
- References
- 62
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 5 · 2021: 10 · 2020: 6 · 2019: 7 · 2018: 9
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-02-06)
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (309718/2015-5)
- Deutscher Akademischer Austauschdienst
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- AM404, paracetamol metabolites, microglia, prostaglandin E2, prostaglandin D2, cyclooxygenase inhibition, cyclooxygenase-1, cyclooxygenase-2, arachidonic acid pathway, lipopolysaccharide, neuroinflammation, anti-inflammatory activity, organotypic hippocampal slices, reactive oxygen species
- MeSH terms
- Acetaminophen, Animals, Anti-Inflammatory Agents, Arachidonic Acids, Cells, Cultured, Mice, Inbred C57BL, Prostaglandins, Cyclooxygenase Inhibitors, Rats, Sprague-Dawley, Microglia, Mice, Rats, Cyclooxygenase 1, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity. https://app.cochat.ai/papers/10.1186/s12974-017-1014-3
- The paper
- Saliba, S. W., Marcotegui, A. R., Fortwängler, E., Ditrich, J., Perazzo, J. C., Muñoz, E., de Oliveira, A. C. P., & Fiebich, B. L. (2017). AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-017-1014-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.